SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy

BACKGROUND: Prostate cancer (PC) is a commonly diagnosed malignancy in males, especially in the western hemisphere. The extensive use of multiple biomarkers plays an important role in the diagnosis and prognosis of PC. However, the accuracy of biomarkers for PC prognosis needs to be urgently improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Zhang, Wanfeng, Song, Jing, Zhang, Xianqin, Ran, Longke, He, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617673/
https://www.ncbi.nlm.nih.gov/pubmed/31288850
http://dx.doi.org/10.1186/s13148-019-0693-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617673/
https://www.ncbi.nlm.nih.gov/pubmed/31288850
http://dx.doi.org/10.1186/s13148-019-0693-2

Ejemplares similares